ATE490339T1 - Diagnostikum für osteoporose - Google Patents
Diagnostikum für osteoporoseInfo
- Publication number
- ATE490339T1 ATE490339T1 AT04780660T AT04780660T ATE490339T1 AT E490339 T1 ATE490339 T1 AT E490339T1 AT 04780660 T AT04780660 T AT 04780660T AT 04780660 T AT04780660 T AT 04780660T AT E490339 T1 ATE490339 T1 AT E490339T1
- Authority
- AT
- Austria
- Prior art keywords
- osteoporosis
- diagnostic
- haplotype
- therapeutics
- diagnostics
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- 108010002352 Interleukin-1 Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 102000054766 genetic haplotypes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49386103P | 2003-08-08 | 2003-08-08 | |
| PCT/US2004/025858 WO2005013809A2 (en) | 2003-08-08 | 2004-08-09 | Diagnostic and therapeutics for osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE490339T1 true ATE490339T1 (de) | 2010-12-15 |
Family
ID=34135292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04780660T ATE490339T1 (de) | 2003-08-08 | 2004-08-09 | Diagnostikum für osteoporose |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7723028B2 (enExample) |
| EP (1) | EP1680513B1 (enExample) |
| JP (1) | JP2007501627A (enExample) |
| KR (1) | KR20060061350A (enExample) |
| CN (1) | CN1863928A (enExample) |
| AT (1) | ATE490339T1 (enExample) |
| AU (1) | AU2004263184B2 (enExample) |
| CA (1) | CA2534365A1 (enExample) |
| DE (1) | DE602004030367D1 (enExample) |
| WO (1) | WO2005013809A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090023147A1 (en) * | 1999-08-30 | 2009-01-22 | Kenneth Kornman | Diagnostics and therapeutics for osteoporosis |
| US20070264645A1 (en) * | 2002-01-25 | 2007-11-15 | Kenneth Kornman | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| DE602004030367D1 (de) | 2003-08-08 | 2011-01-13 | Interleukin Genetics Inc | Diagnostikum für osteoporose |
| US8105775B2 (en) * | 2005-10-25 | 2012-01-31 | Interleukin Genetics, Inc. | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| US8101360B2 (en) * | 2006-11-15 | 2012-01-24 | Interleukin Genetics, Inc. | IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same |
| KR100909709B1 (ko) * | 2007-03-30 | 2009-07-30 | 대한민국 | 골밀도 및 골절 위험과 ｉｔｇａ１ 유전자 다형성과의연관성 |
| US20100112570A1 (en) * | 2008-10-22 | 2010-05-06 | Interleukin Genetics, Inc. | Genetic Markers for Weight Management and Methods of Use Thereof |
| WO2010083294A2 (en) * | 2009-01-16 | 2010-07-22 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for osteoporosis |
| WO2017123696A1 (en) | 2016-01-12 | 2017-07-20 | Interleukin Genetics, Inc. | Methods for predicting response to treatment |
| US10337070B2 (en) | 2017-01-12 | 2019-07-02 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| CA3142662A1 (en) | 2019-06-06 | 2020-12-10 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| WO2021028469A1 (en) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions and methods for treating cytokine release syndrome and neurotoxicity |
| WO2021205013A1 (en) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions and methods for treating covid-19 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4833080A (en) | 1985-12-12 | 1989-05-23 | President And Fellows Of Harvard College | Regulation of eucaryotic gene expression |
| US4998617A (en) | 1986-09-15 | 1991-03-12 | Laura Lupton Inc | Facial cosmetic liquid make up kit |
| CA1316520C (en) | 1987-05-19 | 1993-04-20 | Larry C. Hamilton | Valve |
| US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
| FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| WO1992015694A1 (en) | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| WO1993011149A1 (en) | 1991-12-03 | 1993-06-10 | Thomas Jefferson University | Methods of detecting a genetic predisposition for osteoporosis |
| WO1994003633A1 (en) | 1992-07-31 | 1994-02-17 | Garvan Institute Of Medical Research | Assessment of trans-acting factors allelic variation |
| JP3472587B2 (ja) | 1992-08-28 | 2003-12-02 | アベンティス ファーマ株式会社 | 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法 |
| DE69333641T2 (de) | 1992-12-28 | 2005-11-03 | Baylink, David Jeston, Redlands | Methode zur messung der knochenresorption |
| DE69433811T2 (de) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | Dns - sequenzierung durch massenspektronomie |
| IL108947A0 (en) | 1993-03-12 | 1994-06-24 | Osteopharm Ltd | Bone stimulating factor |
| US5593826A (en) | 1993-03-22 | 1997-01-14 | Perkin-Elmer Corporation, Applied Biosystems, Inc. | Enzymatic ligation of 3'amino-substituted oligonucleotides |
| CA2164498C (en) | 1993-07-09 | 2007-09-11 | Paul A. Price | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| US5686246A (en) | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5942390A (en) | 1996-01-12 | 1999-08-24 | Cedars-Sinai Medical Center | Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism |
| US5698399A (en) | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| GB9621129D0 (en) | 1996-10-10 | 1996-11-27 | Duff Gordon W | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| GB9706359D0 (en) | 1997-03-27 | 1997-05-14 | Gemini International Holdings | Polymorphisms of an il-1 receptor antagonist gene |
| GB9711040D0 (en) | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| DE60026150T2 (de) | 1999-08-30 | 2006-11-16 | Interleukin Genetics, Inc., Waltham | Diagnostika und therapeutika für osteoporose |
| JP2002345500A (ja) * | 2000-12-22 | 2002-12-03 | Pfizer Prod Inc | 炎症性障害を発展させる増加したリスクを検出するための方法および試薬 |
| JP2005500032A (ja) * | 2001-06-15 | 2005-01-06 | インターリューキン ジェネティックス インコーポレイテッド | 老化関連症状の早期発現を検出および治療する方法 |
| DE602004030367D1 (de) | 2003-08-08 | 2011-01-13 | Interleukin Genetics Inc | Diagnostikum für osteoporose |
-
2004
- 2004-08-09 DE DE602004030367T patent/DE602004030367D1/de not_active Expired - Lifetime
- 2004-08-09 CA CA002534365A patent/CA2534365A1/en not_active Abandoned
- 2004-08-09 US US10/914,396 patent/US7723028B2/en not_active Expired - Lifetime
- 2004-08-09 AT AT04780660T patent/ATE490339T1/de not_active IP Right Cessation
- 2004-08-09 JP JP2006523302A patent/JP2007501627A/ja not_active Withdrawn
- 2004-08-09 KR KR1020067002708A patent/KR20060061350A/ko not_active Ceased
- 2004-08-09 AU AU2004263184A patent/AU2004263184B2/en not_active Ceased
- 2004-08-09 WO PCT/US2004/025858 patent/WO2005013809A2/en not_active Ceased
- 2004-08-09 CN CNA2004800291247A patent/CN1863928A/zh active Pending
- 2004-08-09 EP EP04780660A patent/EP1680513B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004263184B2 (en) | 2010-12-02 |
| CA2534365A1 (en) | 2005-02-17 |
| WO2005013809A3 (en) | 2006-01-12 |
| HK1093757A1 (en) | 2007-03-09 |
| EP1680513B1 (en) | 2010-12-01 |
| JP2007501627A (ja) | 2007-02-01 |
| US20050084882A1 (en) | 2005-04-21 |
| US7723028B2 (en) | 2010-05-25 |
| AU2004263184A1 (en) | 2005-02-17 |
| KR20060061350A (ko) | 2006-06-07 |
| EP1680513A2 (en) | 2006-07-19 |
| CN1863928A (zh) | 2006-11-15 |
| EP1680513A4 (en) | 2006-11-08 |
| DE602004030367D1 (de) | 2011-01-13 |
| WO2005013809A2 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE490339T1 (de) | Diagnostikum für osteoporose | |
| NO20040828L (no) | Instrumentert pakning. | |
| NO20070949L (no) | Transkriptomdiagnostikk i spytt | |
| DE602004019614D1 (de) | Medizinische Vorrichtung für Endoskope | |
| DE502004012191D1 (de) | Antriebsstrang für eine Strömungskraftmaschine | |
| EP1954184A4 (en) | MONITORING HUMAN HEALTH ON RESIDUUM BASIS | |
| ATE439868T1 (de) | Targetingmittel für molekulare bilderzeugung | |
| DE60202596D1 (de) | Schaupackung für z.b. eier | |
| NO20051883D0 (no) | Objektglass, dekkglass og patologisk diagnosesystem | |
| DE602004031818D1 (de) | Halbkugelförmiges Ventil für eine medizinische Vorrichtung | |
| DE602005002836D1 (de) | Diagnoseverfahren für erkrankungen unter verwendung von copeptin | |
| DE60116365D1 (de) | Radiopharmazeutika für die diagnose von alzheimer | |
| BR0014150A (pt) | Diagnósticos e terapêuticos para osteoporose | |
| DE60305954D1 (de) | Diagnoseverfahren für eine antennenverbindung | |
| DE602004029061D1 (de) | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes | |
| DE502004011317D1 (de) | Instrument für die plasma-koagulation | |
| DE50301232D1 (de) | Skibindung, insbesondere für den langlauf | |
| NL1023433A1 (nl) | Evaluatie van in de tijd veranderlijke diagnostische processen. | |
| NO20054049D0 (no) | Fremgangsmate for diagnose og behandling. | |
| DE602005014560D1 (de) | Ileitis-diagnosetest | |
| ATE472611T1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
| ATE447628T1 (de) | Einzelsequenzhybridisierungssonden | |
| EP1573055A4 (en) | GENETIC DEPRESSION DIAGNOSIS | |
| EP1616190A4 (en) | DIAGNOSIS OF CANCER IN ADVANCED STADIUM | |
| DE50213745D1 (de) | Verbesserte retrovirale Vektoren für die Gentherapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |